Abstract
Modelling complex smoking histories, with more comprehensive and flexible methods, to show what profile of smoking behavior is associated with the risk of different cancers remains poorly understood. This study aims to provide insight into the association between complex smoking exposure history and pan-cancer risk by modelling both smoking intensity and duration in a large-scale prospective cohort. Here, we used data including a total of 0.5 million with cancer incidences of 12 smoking-related cancers. To jointly interpret the effects of intensity and duration of smoking, we modelled excess relative risks (ERRs)/pack-year isolating the intensity effects for fixed total pack-years, thus enabling the smoking risk comparison for total exposure delivered at low intensity (for long duration) and at a high intensity (for short duration). The pattern observed from the ERR model indicated that for a fixed number of pack-years, low intensity/long duration or high intensity/short duration is associated with a different greater increase in cancer risk. Those findings were extended to an increase of time since smoking cessation (TSC) showing a reduction of ERR/pack-year for most cancers. Moreover, individuals with favorable lifestyle behaviors, such as regular physical activity and healthy dietary intakes, were shown to have lower ERRs/pack-year, compared to those with unfavorable lifestyle behaviors. Overall, this study systematically evaluates and demonstrates that for pan-cancer risks, smoking patterns are varied, while reducing exposure history to a single metric such as pack-years was too restrictive. Therefore, cancer screening guidelines should consider detailed smoking patterns, including intensity, duration, and cessation, for more precise prevention strategies.
Highlights (Key context and significance)
Distinct cancer risk patterns emerge based on smoking exposure beyond equal pack-years: smoking duration is a stronger risk factor for some cancers, while smoking intensity dominates for others.
Time since smoking cessation (TSC) significantly lowers cancer risk: former smokers experience substantial reductions in risk for most cancers within the first 20 years after quitting.
Favorable lifestyle behaviors mitigate cancer risks: individuals with regular physical activity and healthy diets show lower excess relative risks (ERRs) for most cancers, compared to those with unhealthy habits.
Tailored cancer screening based on smoking behavior: cancer screening guidelines should consider detailed smoking patterns, including intensity, duration, and cessation, for more precise prevention strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the: National Natural Science Foundation of China (NSFC, 82204033); the Natural Science Foundation of Jiangsu grant (BK2022020826); Fundamental Research Funds for the Central Universities of China (2242022R10062/3225002202A1), Medical Foundation of Southeast University (4060692202/021), Zhishan Young Scholar Award at the Southeast University (2242023R40031); The Scientific Research Project for Health Commission of Anhui Province (AHWJ2023A20172; AHWJ2023BAa20055). The funders had no role in the study design, data collection, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at UK Biobank.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at UK Biobank.
